Live Breaking News & Updates on Nasdaq Hznp|Page 1
Stay updated with breaking news from Nasdaq hznp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Free Report) in a report published on Tuesday morning. The brokerage issued a strong-buy rating on the biopharmaceutical company’s stock. Separately, Jefferies Financial Group lowered Horizon Therapeutics Public from a buy rating to a hold rating in a research report on Friday, September 1st. […] ....
StockNews.com began coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Free Report) in a research note issued to investors on Tuesday. The firm issued a strong-buy rating on the biopharmaceutical company’s stock. Separately, Jefferies Financial Group cut Horizon Therapeutics Public from a buy rating to a hold rating in a report on Friday, September […] ....
Illinois Municipal Retirement Fund lifted its stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) by 12.6% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 124,257 shares of the biopharmaceutical company’s stock after purchasing an additional 13,921 shares during the […] ....
StockNews.com started coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Free Report) in a research report sent to investors on Monday morning. The brokerage issued a strong-buy rating on the biopharmaceutical company’s stock. Separately, Jefferies Financial Group lowered shares of Horizon Therapeutics Public from a buy rating to a hold rating in a research […] ....
Vanguard Personalized Indexing Management LLC increased its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) by 1.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,706 shares of the biopharmaceutical company’s stock after buying an additional 261 shares during […] ....